title: Effect of hyperketonemia and hyperlacticacidemia on symptoms, cognitive dysfunction, and counterregulatory hormone responses during hypoglycemia in normal humans.
abstract: The brain usually depends almost exclusively on glucose for its energy requirements. During hypoglycemia associated with prolonged fasting or strenuous exercise, circulating ketone-body and lactate levels increase several-fold; in both situations, certain signs and symptoms of hypoglycemia are diminished. Therefore, to test the hypothesis that hyperketonemia or hyperlacticacidemia of the magnitude seen during certain clinical situations can substitute for glucose as an energy source for the brain and alter physiological responses to hypoglycemia, we assessed autonomic and neuroglycopenic symptoms, counterregulatory hormone responses, and cognitive function during standardized insulin-induced hypoglycemia in normal volunteers with and without infusion of beta-hydroxybutyrate (BOHB) or lactate designed to reproduce circulating levels of these substrates seen during prolonged fasting and strenuous exercise. Compared with paired control experiments, infusion of BOHB and lactate increased the glycemic threshold (required greater hypoglycemia for initiation) and reduced the magnitude of autonomic and neuroglycopenic symptoms, counterregulatory hormone responses, and cognitive dysfunction (all P < 0.05). The hypoglycemic threshold for autonomic symptoms increased from 3.8 +/- 0.1 to 3.1 +/- 0.2 mmol/l during BOHB infusion and from 3.7 +/- 0.1 to 2.8 +/- 0.1 mmol/l during lactate infusion, and the threshold for neuroglycopenic symptoms increased from 2.8 +/- 0.1 to 2.4 +/- 0.1 and 2.3 +/- 0.1 mmol/l, respectively. The magnitude for autonomic symptoms decreased from 12 +/- 2 and 11 +/- 1 to 6 +/- 2 and 4 +/- 1 during BOHB and lactate infusion, respectively. Neuroglycopenic synptoms decreased from 11 +/- 2 to 3 +/- 1 during both series of experiments.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: General Clinical Research Center, University of Pittsburgh, Pennsylvania.
authors.forename: T
authors.initials: T
authors.lastname: Veneman
authors.forename: A
authors.initials: A
authors.lastname: Mitrakou
authors.forename: M
authors.initials: M
authors.lastname: Mokan
authors.forename: P
authors.initials: P
authors.lastname: Cryer
authors.forename: J
authors.initials: J
authors.lastname: Gerich
mesh_terms: D020155:3-Hydroxybutyric Acid; D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D003071:Cognition / Q000187:drug effects / Q000502:physiology*; D005260:Female; D006728:Hormones / Q000097:blood*; D006801:Humans; D006885:Hydroxybutyrates; D007003:Hypoglycemia / Q000097:blood* / Q000523:psychology*; D007262:Infusions, Intravenous; D007328:Insulin / Q000097:blood; D007657:Ketone Bodies / Q000097:blood*; D007773:Lactates / Q000097:blood*; D019344:Lactic Acid; D008297:Male; D012016:Reference Values
chemical_list: D001786:Blood Glucose; D006728:Hormones; D006885:Hydroxybutyrates; D007328:Insulin; D007657:Ketone Bodies; D007773:Lactates; D019344:Lactic Acid; D020155:3-Hydroxybutyric Acid